Innovative Health Financing Mechanisms: the Case Of Africa's Unified Approach to Vaccine Acquisition
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Korir J, Gichohi-Wainaina W, Park O, Kwon S, Colwell M, Oldewage-Theron W Nutrients. 2025; 17(2).
PMID: 39861339 PMC: 11767728. DOI: 10.3390/nu17020209.
References
1.
Stein F
. Risky business: COVAX and the financialization of global vaccine equity. Global Health. 2021; 17(1):112.
PMC: 8451387.
DOI: 10.1186/s12992-021-00763-8.
View
2.
Ihekweazu C
. Lessons from Nigeria's Adaptation of Global Health Initiatives during the COVID-19 Pandemic. Emerg Infect Dis. 2022; 28(13):S299-S301.
PMC: 9745227.
DOI: 10.3201/eid2813.221175.
View
3.
Cernuschi T, Furrer E, Schwalbe N, Jones A, Berndt E, McAdams S
. Advance market commitment for pneumococcal vaccines: putting theory into practice. Bull World Health Organ. 2012; 89(12):913-8.
PMC: 3260895.
DOI: 10.2471/BLT.11.087700.
View
4.
Ngoy N, Oyugi B, Ouma P, Conteh I, Fisseha Woldetsadik S, Nanyunja M
. Coordination mechanisms for COVID-19 in the WHO Regional office for Africa. BMC Health Serv Res. 2022; 22(1):711.
PMC: 9142827.
DOI: 10.1186/s12913-022-08035-w.
View
5.
Cernuschi T, Gaglione S, Bozzani F
. Challenges to sustainable immunization systems in Gavi transitioning countries. Vaccine. 2018; 36(45):6858-6866.
PMC: 6203805.
DOI: 10.1016/j.vaccine.2018.06.012.
View